Individual Manufacturing Medical Provider Provider 
Physician's Weekly
JUNE 18, 2025
Society all too often conceptualizes obesity as a problem of individual willpower, which could reduce the demand for pharmacological treatments among those who are most affected and who have the potential for greatest benefit,” the researchers said.
FDA Law
MAY 26, 2025
Specifically, these are procedures and drugs used in providing what HHS had, until recently, referred to as gender-affirming care. Department of Health & Human Services purporting to provide a comprehensive review of the evidence and best practices for promoting the health of children and adolescents with gender dysphoria.
Expert insights. Personalized for you.
52 
Let's personalize your content